• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Drug-Device Combinations

SpyGlass Pharma raises $75M for drug delivery platform

June 2, 2025 By Sean Whooley

SpyGlass Pharma Intraocular Lens IOL drug delivery platform

SpyGlass Pharma announced today that it closed a $75 million Series D financing round to support its drug delivery platform. Sands Capital led the financing round, with Gilde Healthcare also joining. Existing investors New Enterprise Associates (NEA), RA Capital, Vensana Capital, Samsara BioCapital and Vertex Ventures HC participated. The company said funds support its drug […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Funding Roundup, Implants, Optical/Ophthalmic Tagged With: SpyGlass Pharma

Modular Medical adds insulin delivery tech veteran to board

May 29, 2025 By Sean Whooley

Modular Medical modd1 insulin pump

Modular Medical (Nasdaq:MODD) announced that it appointed industry veteran Jeff Goldberg to its board of directors. Goldberg brings decades of experience in healthcare, life sciences and medical device leadership. His track record includes taking part in the development of generic insulin. Goldberg also began his work in medtech alongside MiniMed founder Alfred E. Mann. “We are […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Personnel Tagged With: modularmedical, Personnel Moves

Tandem agrees to pay $36M to settle Roche patent litigation

May 29, 2025 By Sean Whooley

Tandem Diabetes Care Roche

Tandem Diabetes Care (Nasdaq:TNDM) recently filed an SEC Form 8-K announcing its entry into a patent litigation settlement with Roche. The two companies entered into a settlement, mutual release and cross-license agreement. It resolves all actual or potential patent disputes as of May 21. According to the SEC filing, the settlement relates to Tandem’s t:slim […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Legal News, Regulatory/Compliance, Technology Tagged With: Roche, Roche Diabetes Care, Tandem Diabetes Care

Vivani files with SEC to spin off neurostim business, focus on drug delivery implants

May 29, 2025 By Sean Whooley

Vivani Medical Cortigent

Vivani Medical (Nasdaq:VANI) announced today that it filed a Form 10 registration statement with the SEC to spin off its neurostimulation unit. The company said earlier this year that it plans to spin off Cortigent, a division that develops brain implants. The company wants to create two focused companies dedicated to driving current and future […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Implants, Neurological Tagged With: Cortigent, Vivani Medical

Senseonics closes public offering, private placement with Abbott

May 22, 2025 By Sean Whooley

Senseonics logo

Senseonics (NYSE:SENS) announced that it closed its previously announced public offering and private placement with Abbott. Last week, the long-term continuous glucose monitor maker said it commenced an underwritten public offering of common stock worth $50 million. At the same time, it entered into a securities purchase agreement with another CGM maker — Abbott. Under […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Funding Roundup, Implants, Patient Monitoring, Technology Tagged With: Senseonics

Embecta eyes shift from insulin delivery to broader medical supplies focus

May 22, 2025 By Sean Whooley

BD Diabetes Spinoff Embecta

Embecta (Nasdaq:EMBC) today revealed its phased plan to create value and shift priorities toward broader medical applications. The pure-play diabetes technology company has endured ups and downs since its 2022 spin-off from BD. That includes an FDA approval for a disposable insulin patch pump system in September 2024, only to be followed by the discontinuation […]

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Wall Street Beat Tagged With: embecta

Medtronic earns expanded CE mark for Prevail paclitaxel-coated balloon

May 22, 2025 By Sean Whooley

Medtronic Prevail drug-coated balloon

Medtronic announced today that it received CE mark for several expanded indications for its Prevail balloon catheter. The expanded indications for the paclitaxel-coated percutaneous transluminal coronary angioplasty (PTCA) balloon catheter (or drug-coated balloon/DCB) cover the treatment of coronary artery disease (CAD). According to the medtech giant, Prevail now has the broadest range of CE mark […]

Filed Under: Cardiovascular, Clinical Trials, Drug-Device Combinations, Regulatory/Compliance, Vascular Tagged With: Medtronic

Sequel Med Tech to pair automated insulin delivery system with Abbott’s future dual glucose-ketone sensor

May 22, 2025 By Sean Whooley

Abbott FreeStyle Libre 3 Plus Sequel Med Tech Twiist

Sequel Med Tech announced today that it agreed to integrate its twiist automated insulin delivery system with a future Abbott sensor. The companies agreed to pair twiist, powered by Tidepool, with Abbott‘s glucose-ketone sensor, currently under development. Sequel said the agreement aims to improve outcomes for people with type 1 diabetes. It adds ketone sensing capabilities […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: abbott, Sequel Med Tech

Medtronic to separate Diabetes business unit

May 21, 2025 By Sean Whooley

Medtronic Simplera Sync CGM with MiniMed 780G (1)

Medtronic (NYSE:MDT) announced today that it intends to separate its Diabetes business into a new standalone company. The medtech giant said the strategic decision can create “a more focused Medtronic” with a more simplified portfolio in high-margin growth markets. At the same time, it creates an independent, scaled leader in diabetes. The new company — […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Initial Public Offering (IPO), MassDevice Earnings Roundup, Patient Monitoring, Technology, Wall Street Beat Tagged With: Medtronic

Tandem Diabetes Care wins CE mark for Mobi insulin pump with Control-IQ+ technology

May 20, 2025 By Sean Whooley

Tandem Diabetes Mobi insulin patch pump worn on hiker's leg drug delivery

Tandem Diabetes Care (Nasdaq:TNDM) filed an SEC Form 8-K to state that it received CE mark for its Mobi insulin delivery system. San Diego-based Tandem can now market the miniature, durable automated insulin delivery system with Control-IQ+ technology in Europe. According to the filing, the company intends to pursue additional regulatory and pre-commercial activities now. […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Regulatory/Compliance, Technology Tagged With: Tandem Diabetes Care

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Interim pages omitted …
  • Page 333
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS